DSA21 - Opioid Abuse and Treatment

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/39

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

40 Terms

1
New cards

What is the most important subtype of Opioid receptors for abuse and dependence?

Mu/µ

2
New cards

Where are Opioid Mu receptors expressed?

Selectively on GABAergic neurons in the Ventral Tegmental Area (VTA) --> decrease firing of DA neurons

3
New cards

What happens if Opioid Mu receptors are activated (stops GABA activity on VTA)?

Increases DA neuronal activity w/ increased DA release into Nucleus accumbens (reward center)

4
New cards

Describe how Opioid Abuse occurs

-Euphoria (may take multiple uses)

-More frequent use at higher dose (oral/skin popping --> smoking/injecting)

5
New cards

Morphine MoA

Opioid Agonist; obtained from opium poppy

6
New cards

Morphine S/E

Abused via prescription diversion - more potent parentally

7
New cards

Heroin MoA

Opioid Agonist - morphine + 2 acetate groups; more lipid soluble than morphine (quicker access to brain); PRO-DRUG (metabolized to morphine in brain)

8
New cards

Heroin Effects

Often mixed w/ Fentanyl --> 1 min effects = Warmth, "Rush", Intense Euphoria then Modest Euphoria (45-60 min)

9
New cards

Fentanyl MoA

Opioid Agonist - more potent than other opioids

10
New cards

Methadone MoA

Opioid Agonist - HIGHEST ORAL POTENCY; Effects ~ 24 hrs

11
New cards

Methadone Uses

Tx of Cancer Pain & Tx of Opioid addiction, Replacement-Maintenance Therapy (long-half lives to keep opioid receptors occupied)

12
New cards

Oxymorphone MoA

Opioid Agonist

13
New cards

Hydromorphone MoA

Opioid Agonist

14
New cards

Oxycodone MoA

Moderate Efficacy Opioids; time release formula

15
New cards

Oxycodone S/E

Significant abuse liability

16
New cards

Hydrocodone MoA

Moderate Efficacy Opioids

17
New cards

Hydrocodone S/E

Significant abuse liability

18
New cards

Codeine MoA

Low Efficacy Opioids; obtained from opium poppy - converted to morphine by liver --> binds to Sigma receptor (with higher dose --> unpleasant psychotomimetic effects)

19
New cards

Codeine S/E

Abuse potential

20
New cards

Tramadol MoA

Low Efficacy Opioids; Schedule IV; Very WEAK Mu-receptor effects + Pain-Relief (acts on NE & Serotonin)

21
New cards

Tramadol S/E

Less Abuse potential

22
New cards

Rate of Opioid Tolerance development varies among agents but general develops faster with more () and/or () doses

potent; higher

23
New cards

What does it mean to say that there's specificity of tolerance development with Opioids?

Means there's little to no tolerance to the miosis-producing and constipating effects of opioids

24
New cards

What are S/S of Opioid Withdrawal?

-DRUG CRAVING

-RHINORRHEA

-Lacrimation

-YAWNING

-CHILLS

-Piloerection

-Hyperventilation

-Hyperthermia

-MYDRIASIS

-Vomiting

-Diarrhea

-ANXIETY

25
New cards

When does Opioid Withdrawal occur in relation to cessation of substance use?

-Short Acting Opioid = 6-12 hrs after last dose

-Long Acting Opioid = 72+ hrs after last dose

26
New cards

What should be done to Tx Opioid Withdrawal?

NOTHING (Non-lethal) --> Detox w/ Methadone or Buprenorphine

27
New cards

Buprenorphine MoA

Low Efficacy Opioids; Schedule III; Weak Mu partial agonist w/ slow dissociation from Mu receptors (clings tightly to receptors --> high dose = all Mu receptors covered)

28
New cards

Buprenorphine Uses

Tx of Opioid Dependence, Replacement-Maintenance Therapy, Replacement-Maintenance Therapy (long-half lives to keep opioid receptors occupied)

29
New cards

Buprenorphine S/E

Likelihood of abuse --> Add Naloxone to reduce likelihood

30
New cards

Clonidine MoA

Alpha2 Agonst - acts in brainstem to reduce Sympathetic activation

31
New cards

Clonidine Uses

Tx of Opioid Withdrawal (part of supportive Rx to minimizeSNS Activation of Withdrawal s/s WITHOUT maintaining independence)

32
New cards

Lofexidine MoA

Alpha2 Agonst - acts in brainstem to reduce Sympathetic activation

33
New cards

Lofexidine Uses

Tx of Opioid Withdrawal (part of supportive Rx to minimizeSNS Activation of Withdrawal s/s WITHOUT maintaining independence)

34
New cards

What are the Primary S/S of Opioid O/D?

-Lethargy or coma

-Depressed respiration

-Pinpoint pupils (normoxic)

-Needle marks

35
New cards

What are the Secondary S/S of Opioid O/D?

-Hypotension

-Hypothermia with cold or clammy skin

-Pulmonary edema

-Convulsions (primarily in children)

-Hypoxia with dilated pupils (just before death)

36
New cards

Naloxone MoA

Opioid Antagonist - Short Acting

37
New cards

Naloxone Uses

Injectable for Opioid O/D (used in ED), Intranasal, Used in SUBLOXONE (Sublingual form; Buprenoprhine + This --> reduce abuse likelihood)

38
New cards

Naltrexone MoA

Opioid Antagonist - Long Acting

39
New cards

Naltrexone Uses

Oral, Tx Chronic Opioid Abuse OR Alcoholism

40
New cards

What should be done to prevent Opioid Abuse Relapse?

Medication-Assisted Therapy